" class="no-js "lang="en-US"> Justin Thacker - Medtech Alert
Tuesday, April 16, 2024
Justin Thacker

Justin Thacker

About Justin Thacker

Accomplished, hands-on senior finance and accounting leader in the life science industry with more than 25 years of progressive experience within organizations ranging from pre-clinical to commercial operations. Broad knowledge and significant experience in numerous areas including:
• Budgeting and financial modeling
• SEC reporting and compliance
• Initial public offerings and follow-on offerings
• Equity and debt fundraising
• Mergers and acquisitions
• Valuation analysis (409A)
• Treasury and cash management
• Accounting operations and financial close processes
• Internal controls
• Technical accounting
• 401(k) administration
• Stock administration and equity valuation
• Quarterly conference calls and financial releases
• Tax filings and compliance
• 382/383 studies
• Board material and presentations
• Clinical trial accruals
• Initial product launches
• Order-to-cash process
• Specialty and wholesaler distribution models
• Medicare and Medicaid reimbursement
• International subsidiaries and transfer pricing
• Revenue recognition and gross-to-net elements
• Inventory accounting
• ERP implementation

Related Story

Aristea Appoints Justin Thacker as Chief Financial Officer

August 24 2021

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]